IlluMyFi

CervoMed (NASDAQ: CRVO) has recently received a number of price target changes and ratings updates: 12/17/2024 – CervoMed was downgraded by analysts at HC Wainwright from a “buy” rating to a “neutral” rating. 12/11/2024 – CervoMed had its “underweight” rating reaffirmed by analysts at Morgan Stanley. 12/11/2024 – CervoMed had its “neutral” rating reaffirmed by [...]

Sentiment

0.59

Bearish/Bullish

100

06.01.25 04:14

by americanbankingnews.com

PACS Group (NYSE:PACS) Price Target Cut to $24.00 by Analysts at Macquarie

PACS Group (NYSE:PACS – Get Free Report) had its price target dropped by Macquarie from $42.00 to $24.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Macquarie’s price objective suggests a potential upside of 77.12% from the company’s previous close. PACS has been the topic [...]

United States of America